Hematology & Stem Cell Transplantation Program

Hematology & Stem Cell Transplantation Program
On June 5, 2013, the FDA approved lenalidomide capsules (Revlimid, Celgene) for the treatment of patients with mantle cell lymphoma whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib. … The Center for … Read more on Clinical Oncology News

University of Maryland Researchers Enrolling Patients to Evaluate Long-Term …
The need for effective long-term treatment can dramatically affect decisions that physicians make regarding which medications to prescribe. We need to help patients better manage this chronic disease and avoid serious complications, such as kidney … Read more on HealthCanal.com

Committee proposes to limit pot production
The use of medical marijuana in Massachusetts was approved by 63 percent of voters in November. In Haverhill, 60 … The new law provides for 35 nonprofit medical marijuana treatment centers throughout the state, with no more than five in each county. Read more on Eagle-Tribune